China Health Holding, a developer, marketer and manufacturer of natural herbal supplement products based on traditional Chinese medicine, announced on Aug 28 that it has retained Investor Relations International (IRI) to lead an expanded shareholder communication program.

As investor relations counsel for China Health, Los Angeles-based IRI will raise investor awareness of the company's performance through a multi-channel campaign. IRI will employ print and electronic media as well as direct communication with money managers and current or prospective shareholders. The IRI program, focused on communicating China Health's expansion strategy across China, seeks both to broaden the Company's shareholder base and to solidify the long-term loyalty of current shareholders.

"We are pleased to have Investor Relations International supporting our efforts to better communicate with our existing shareholders while simultaneously increasing our efforts to attract new investors familiar with our current robust expansion and our prospects for future growth," said Julianna Lu, President and CEO of China Health Holding. "With the rapidly increasing interest in herbal products, global demand for our unique and effective herbal medicinal products and Major China Pharmaceutical Acquisitions has never been stronger.

"The one crucial element we have lacked up to this point is a strong investor-relations program to raise our profile on Wall Street and give us better access to the capital markets should we require it. Our retention of IRI fills that gap, and we expect to benefit from much greater visibility and liquidity from here on."

Source:佚名